Background of diabetes Flashcards

1
Q

Type 1 Diabetes pathophysiology + presentation?

A

Autoimmune disorder where the insulin-producing beta cells of the islets of Langerhans in the pancreas are destroyed by the immune system

This results in an absolute deficiency of insulin resulting in raised glucose levels

Tends to develop in childhood/early adult life and typically present unwell, possibly in diabetic ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type 2 diabetes pathophysiology?

A

Most common cause of diabetes in the developed world

caused by a relative deficiency of insulin due to an excess of adipose tissue

In simple terms there isn’t enough insulin to ‘go around’ all the excess fatty tissue, leading to blood glucose creeping up.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prediabetes term used for?

A

patients who don’t yet meet the criteria for a formal diagnosis of T2DM to be made but are likely to develop the condition over the next few years. They, therefore, require closer monitoring and lifestyle interventions such as weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Gestational diabetes?

A

Some pregnant develop raised glucose levels during pregnancy. This is important to detect as untreated it may lead to adverse outcomes for the mother and baby

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Maturity onset diabetes of the young (MODY)?

A

A group of inherited genetic disorders affecting the production of insulin. Results in younger patients developing symptoms similar to those with T2DM, i.e. asymptomatic hyperglycaemia with progression to more severe complications such as diabetic ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Latent autoimmune diabetes of adults (LADA)

A

The majority of patients with autoimmune-related diabetes present younger in life. There are however a small group of patients who develop such problems later in life. These patients are often misdiagnosed as having T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Other types of diabetes?

A

Any pathological process which damages the insulin-producing cells of the pancreas may cause diabetes to develop. Examples include chronic pancreatitis and haemochromatosis.

Drugs may also cause raised glucose levels. A common example is glucocorticoids which commonly result in raised blood glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Symptoms and signs of Type 1

A

Weight loss
Polydipsia
Polyuria

May present with diabetic ketoacidosis
- abdominal pain
- vomiting
- reduced consciousness level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Signs and symptoms Type 2

A

Often picked up incidentally on routine blood tests
Polydipsia
Polyuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are polydipsia and polyuria due to?

A

water being ‘dragged’ out of the body due to the osmotic effects of excess blood glucose being excreted in the urine (glycosuria).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 4 main ways to check blood glucose?

A

a finger-prick bedside glucose monitor

a one-off blood glucose. This may either be fasting or non-fasting

a HbA1c. This measures the amount of glycosylated haemoglobin and represents the average blood glucose over the past 2-3 months

a glucose tolerance test. In this test, a fasting blood glucose is taken after which a 75g glucose load is taken. After 2 hours a second blood glucose reading is then taken

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The diagnostic criteria: if a patient is symptomatic?

A

fasting glucose greater than or equal to 7.0 mmol/l

random glucose greater than or equal to 11.1 mmol/l (or after 75g oral glucose tolerance test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The diagnostic criteria: if the patient is asymptomatic?

A

fasting glucose greater than or equal to 7.0 mmol/l
random glucose greater than or equal to 11.1 mmol/l (or after 75g oral glucose tolerance test)

MUST be demonstrated on TWO separate occasions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

supplementary guidance on the use of HbA1c for the diagnosis of diabetes:

A

a HbA1c of greater than or equal to 6.5% (48 mmol/mol) is diagnostic of diabetes mellitus

a HbAlc value of less than 6.5% does not exclude diabetes (i.e. it is not as sensitive as fasting samples for detecting diabetes)

in patients without symptoms, the test must be repeated to confirm the diagnosis

it should be remembered that misleading HbA1c results can be caused by increased red cell turnover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Type 1 diabetes general management

A

patients always require insulin to control the blood sugar levels. This is because there is an absolute deficiency of insulin with no pancreatic tissue left to stimulate with drugs

different types of insulin are available according to their duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Type 2 diabetes general management

A

the majority of patients with type 2 diabetes are controlled using oral medication

the first-line drug for the vast majority of patients is metformin

second-line drugs include sulfonylureas, gliptins and pioglitazone. Please see the table below for further information

if oral medication is not controlling the blood glucose to a sufficient degree then insulin is used

17
Q

Insulin: MoA, Route, Main side-effects, Notes

A
  • Direct replacement of endogenous insulin
  • Subcutaneous
  • Hypoglycaemia, weight gain, Lipodystrophy
  • Used in all patients with Type 1, and some patients with poorly controlled Type 2.
18
Q

Metformin: MoA, Route, Main side-effects, Notes

A
  • Increases insulin sensitivity, Decreases hepatic gluconeogenesis
  • Oral
  • Gastrointestinal upset, Lactic acidosis
  • First line medication in the management of Type 2
  • Cannot be used in patients an eGFR of <30 ml/min
19
Q

Sulfonylureas: MoA, Route, Main side-effects, Notes

A
  • Stimulate pancreatic beta cells to secrete insulin
  • Oral
  • Hypoglycaemia, Weight gain, Hyponatraemia
  • Examples include gliclazide and glimepiride
20
Q

Thiazolidinediones: MoA, Route, Main side-effects, Notes

A
  • Activate PPAR-gamma receptor in adipocytes to promote adipogenesis and fatty acid uptake
  • Oral

-Weight gain, fluid retention

  • only currently available thiazolidinedione is pioglitazone
21
Q

DPP-4 Inhibitors (-gliptins): Moa, route, notes

A
  • Increases incretin levels which inhibit glucagon secretion
  • Oral
  • generally well tolerated but increased risk of pancreatitis
22
Q

SGLT-2 inhibitors (gliflozins): MoA, route, side-effects, notes

A
  • inhibits reabsorption of the glucose in the kidney
  • oral
  • UTI
  • typically results in weight loss
23
Q

GLP-1 antagonists (-tides): MoA, route, side-effects, notes

A
  • incretin mimetic which inhibits glucagon secretion
  • subcutaneous
  • Nausea, vomiting, pancreatitis
  • typically result in weight loss
24
Q

Type 2 diabetes: Drug course if metformin tolerated and not CI:

A

Start on metformin, if HbA1c > 58 mmol/mol (7.5%) then do:

Metformin + DPP-4 inhibitor (gliptin)
OR
Metformin + sulfonylurea
OR
Metformin + pioglitazone
OR
Metformin + SGLT-2 inhibitor

if HbA1c still >58 mmol/mol (7.5%) then:

Insulin +

Metformin + DPP-4 inhibitor (gliptin) + sulfonylurea
OR
Metformin + sulfonylurea + pioglitazone
OR
Metformin + pioglitazone + sulfonylurea
OR
Metformin + SGLT-2 inhibitor + pioglitazone

if triple therapy “not effectivem not tolerated or CI” AND >BMI 35 then:

Metformin + sulfonylurea + GLP-1 mimetic

25
Q

Type 2 diabetes: drug course if metformin not tolerated or CI

A

DPP-4 inhibitor (Gliptin)
OR
Sulfonylurea
OR
Pioglitazone

if HbA1c >58 mmol/mol (7.5%) then:

Gliptin + pioglitazone
OR
Gliptin + sulfonylurea
OR
Pioglitazone + sulfonylurea

if HbA1c >58 mmol/mol (7.5%) then + insulin

26
Q

Anti-islet autoantibodies are predictive and diagnostic markers of ?

A

T1D

The most frequently detected autoantibodies are GAD autoantibodies (80) followed by IA-2 autoantibodies (60)

27
Q

HbA1c to diagnose T2D?

A

HbA1c at or above 48mmol/mol